Your browser doesn't support javascript.
loading
Discovery of the main active constituents of siwu mixture for reversing the multidrug resistance of human erythrocyte leukemic cell line K562/ADM / 中国中药杂志
China Journal of Chinese Materia Medica ; (24): 520-523, 2005.
Artículo en Chino | WPRIM | ID: wpr-279123
ABSTRACT
<p><b>OBJECTIVE</b>To study the main active constituents of Siwu mixture for reversing the multidrug resistance (MDR) of human erythrocyte leukemic cell line K562/ADM.</p><p><b>METHOD</b>Macroporous resin was used to separate Siwu mixture and an in vitro model was used to evaluate the reversal index of each fraction for discovery of active fraction. HPLC-MS was used for investigating the main active constituents of Siwu mixture.</p><p><b>RESULT</b>The reversal index of the gross polysaccharide of Rehmannia glutinosa was significantly higher than that of blank control (P < 0.01). There was little difference between the reversal effect of the gross polysaccharide of Rehmannia glutinosa and that of the active fraction A (P > 0.05).</p><p><b>CONCLUSION</b>The gross polysaccharide of Rehmannia glutinosa is one of the main active constituents of Siwu mixture.</p>
Asunto(s)
Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Farmacología / Plantas Medicinales / Polisacáridos / Medicamentos Herbarios Chinos / Doxorrubicina / Química / Resistencia a Múltiples Medicamentos / Resistencia a Antineoplásicos / Células K562 / Ligusticum Límite: Humanos Idioma: Chino Revista: China Journal of Chinese Materia Medica Año: 2005 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Farmacología / Plantas Medicinales / Polisacáridos / Medicamentos Herbarios Chinos / Doxorrubicina / Química / Resistencia a Múltiples Medicamentos / Resistencia a Antineoplásicos / Células K562 / Ligusticum Límite: Humanos Idioma: Chino Revista: China Journal of Chinese Materia Medica Año: 2005 Tipo del documento: Artículo